Mycolic acids for the control of tuberculosis

Author： Sekanka Gianna   Baird Mark   innikin David   Grooten Johan  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.17, Iss.3, 2007-03, pp. : 315-331

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drugs that Inhibit Mycolic Acid Biosynthesis in Mycobacterium tuberculosis

By  

Current Pharmaceutical Biotechnology, Vol. 3, Iss. 3, 2002-01 ,pp. : 197-225

Bentham Science Publishers

Access to resources Recommend Favorite

New Approaches to Target the Mycolic Acid Biosynthesis Pathway for the Development of Tuberculosis Therapeutics

By  

Current Pharmaceutical Design, Vol. 20, Iss. 27, 2014-01 ,pp. : 4357-4378

Bentham Science Publishers

Access to resources Recommend Favorite

Drugs that Inhibit Mycolic Acid Biosynthesis in Mycobacterium tuberculosis - An Update

By  

Medicinal Chemistry Reviews - Online, Vol. 2, Iss. 5, 2005-10 ,pp. : 393-413

Bentham Science Publishers

Access to resources Recommend Favorite

Diversity and Functionality of Mycobacterial Mycolic Acids in Relation to Host-pathogen Interactions

By  

Current Medicinal Chemistry, Vol. 24, Iss. 38, 2017-12 ,pp. : 4267-4278

Bentham Science Publishers

Access to resources Recommend Favorite

Tuberculosis

By Goodman Anna   Lipman Marc  

Clinical Medicine, Vol. 8, Iss. 5, 2008-10 ,pp. : 531-534

Royal College Of Physicians

Access to resources Recommend Favorite